Form 4: GeneDx Holdings Corp. CEO Katherine Stueland Reports Stock Transactions
SEC Form 4 Filing
Katherine Stueland, CEO of GeneDx Holdings Corp., reports the acquisition and disposal of Class A Common Stock related to restricted stock units.
Summary
- On April 29, 2024, Katherine Stueland, CEO of GeneDx Holdings Corp., engaged in transactions involving the company's Class A Common Stock.
- Stueland acquired 15,496 shares through the vesting of restricted stock units (RSUs) at a price of $0.
- Simultaneously, she sold 6,325 shares at $11.0368 per share to cover tax withholding obligations associated with the RSU vesting.
- Following these transactions, Stueland directly owns 75,869 shares of Class A Common Stock and 30,992 restricted stock units.
- The RSUs vest in installments, with 25% vesting annually on April 29, 2023 and April 29, 2024, and the remaining 50% vesting quarterly thereafter, contingent upon continued service.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing related to stock transactions by an executive. The sale of shares for tax purposes is a normal occurrence.
Positives
- The vesting of RSUs indicates a continued alignment of the CEO's interests with the company's performance.
Negatives
- The sale of shares, even for tax obligations, could be perceived negatively by some investors, although it's a common practice.
Risks
- There are no specific risks mentioned in this document, but any significant stock sales by key executives could potentially impact investor confidence.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The sale of shares to cover taxes is a common practice.
Stakeholder Impact
- The transactions are unlikely to have a significant impact on stakeholders, as they are related to routine executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| 04/29/2023 | 25% of the underlying shares of the Restricted Stock Units vest. |
| 04/29/2024 | Date of transaction: Acquisition of 15,496 shares through RSU vesting and sale of 6,325 shares for tax obligations; 25% of the underlying shares of the Restricted Stock Units vest. |
| 04/30/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.